Skip to content

Comparison of Morning or Evening Antihypertensive Drugs on Albuminuria (The MORE trial): A Randomized Control Trial

Comparison of Morning or Evening Antihypertensive Drugs on Albuminuria (The MORE trial): A Randomized Control Trial

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220722005
Enrollment
60
Registered
2022-07-22
Start date
2021-03-08
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with hypertension presenting albuminuria more than 30 mg/g and taking more than one antihypertensive class more than 3 months albuminuria, albumin creatinine ratio, evening, hypertension, morning

Interventions

received pills in the morning 6 to 10 am,received pills in the evening 6 to 10 pm
Morning group,Evening group

Sponsors

Navamindradhiraj University, Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age 18-80 year Hypertension for more than 1 year At least one antihypertensive agent for more than 3 months and at least one antihypertensive agent in Angiotensin-converting enzyme inhibitor (ACEI) and/or Angiotensin receptor blocker (ARB) Well controlled blood pressure (systolic blood pressure < 150 mmHg, Diastolic blood pressure < 90 mmHg) albuminuria > 30 mg/g Renal function (estimated glomerular filtration rate, eGFR > 15 ml/min/1.73 m2)

Exclusion criteria

Exclusion criteria: End stage kidney disease Poor control blood pressure Severe comorbid disease for example congestive heart failure, active cancer Pregnancy Inflammatory disease or active infection for example arthritis, pyelonephritis Study termination criteria Flare of comorbid disease or active infection (Cancer, acute coronary syndrome or any underlying disease that effect renal function) after included in study

Design outcomes

Primary

MeasureTime frame
Urine albumin creatinine ratio 3 months after intervention UACR

Secondary

MeasureTime frame
Effect to serum creatinine 3 months after intervention serum creatinine ,Effects of blood pressure 3 months after intervention Systolic and diastolic blood pressure

Countries

Thailand

Contacts

Public ContactThanphisit Trakarnvanich

Faculty of Medicine, Navamindradhiraj University

thanphisit@nmu.ac.th0896996830

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026